Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Isomedix is a leading provider of contract sterilization services for the medical device, pharmaceutical, and consumer product industries. Founded in 1972, the company specializes in gamma irradiation and ethylene oxide sterilization technologies to ensure the safety and sterility of healthcare products. In 1997, Isomedix was acquired by STERIS Corporation and now operates as part of STERIS Applied Sterilization Technologies (AST). The company maintains a global network of facilities providing critical microbial reduction and sterilization solutions. Its services are essential for manufacturers requiring validated sterilization processes that meet stringent regulatory standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Isomedix Technology.